Susquehanna International Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,206
Closed -$116K 6860
2024
Q2
$116K Buy
15,206
+5,012
+49% +$38.1K ﹤0.01% 5042
2024
Q1
$91.7K Buy
+10,194
New +$91.7K ﹤0.01% 5033
2023
Q4
Sell
-1,120
Closed -$6.79K 6854
2023
Q3
$6.79K Buy
1,120
+184
+20% +$1.12K ﹤0.01% 5359
2023
Q2
$6.46K Sell
936
-5,361
-85% -$37K ﹤0.01% 5474
2023
Q1
$98.9K Buy
+6,297
New +$98.9K ﹤0.01% 5258
2022
Q4
Sell
-2,675
Closed -$48K 7054
2022
Q3
$48K Buy
2,675
+887
+50% +$15.9K ﹤0.01% 5512
2022
Q2
$40K Buy
1,788
+1,123
+169% +$25.1K ﹤0.01% 5296
2022
Q1
$18K Sell
665
-2,707
-80% -$73.3K ﹤0.01% 5491
2021
Q4
$153K Sell
3,372
-4,065
-55% -$184K ﹤0.01% 5111
2021
Q3
$620K Sell
7,437
-3,729
-33% -$311K ﹤0.01% 3407
2021
Q2
$1.06M Sell
11,166
-13,914
-55% -$1.32M ﹤0.01% 2897
2021
Q1
$4.17M Buy
25,080
+23,728
+1,755% +$3.95M ﹤0.01% 1381
2020
Q4
$132K Buy
+1,352
New +$132K ﹤0.01% 4415
2019
Q2
Sell
-106
Closed -$18K 5151
2019
Q1
$18K Sell
106
-69
-39% -$11.7K ﹤0.01% 2846
2018
Q4
$19K Buy
+175
New +$19K ﹤0.01% 3459
2018
Q3
Hold
0
4957
2018
Q2
Sell
-357
Closed -$886K 4950
2018
Q1
$886K Buy
+357
New +$886K ﹤0.01% 1597
2016
Q4
Sell
-40
Closed -$44K 4897
2016
Q3
$44K Buy
+40
New +$44K ﹤0.01% 2795
2016
Q1
Sell
-14
Closed -$14K 4529
2015
Q4
$14K Hold
14
﹤0.01% 4133
2015
Q3
$15K Sell
14
-1
-7% -$1.07K ﹤0.01% 4095
2015
Q2
$31K Buy
+15
New +$31K ﹤0.01% 4366
2015
Q1
Sell
-30
Closed -$31K 4573
2014
Q4
$31K Buy
30
+8
+36% +$8.27K ﹤0.01% 4310
2014
Q3
$23K Sell
22
-12
-35% -$12.5K ﹤0.01% 3798
2014
Q2
$65K Sell
34
-5
-13% -$9.56K ﹤0.01% 4087
2014
Q1
$83K Sell
39
-79
-67% -$168K ﹤0.01% 3396
2013
Q4
$274K Sell
118
-56
-32% -$130K ﹤0.01% 3286
2013
Q3
$490K Buy
174
+146
+521% +$411K ﹤0.01% 2624
2013
Q2
$262K Buy
+28
New +$262K ﹤0.01% 2979